Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244067/ https://www.ncbi.nlm.nih.gov/pubmed/37150612 http://dx.doi.org/10.5551/jat.ER63659 |
_version_ | 1785054560948060160 |
---|---|
author | Nakamura, Akihiro Kagaya, Yuta Saito, Hiroki Kanazawa, Masanori Sato, Kenjiro Miura, Masanobu Kondo, Masateru Endo, Hideaki |
author_facet | Nakamura, Akihiro Kagaya, Yuta Saito, Hiroki Kanazawa, Masanori Sato, Kenjiro Miura, Masanobu Kondo, Masateru Endo, Hideaki |
author_sort | Nakamura, Akihiro |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10244067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Japan Atherosclerosis Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-102440672023-06-08 Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study Nakamura, Akihiro Kagaya, Yuta Saito, Hiroki Kanazawa, Masanori Sato, Kenjiro Miura, Masanobu Kondo, Masateru Endo, Hideaki J Atheroscler Thromb Erratum Japan Atherosclerosis Society 2023-06-01 2023-05-02 /pmc/articles/PMC10244067/ /pubmed/37150612 http://dx.doi.org/10.5551/jat.ER63659 Text en 2023 Japan Atherosclerosis Society https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) |
spellingShingle | Erratum Nakamura, Akihiro Kagaya, Yuta Saito, Hiroki Kanazawa, Masanori Sato, Kenjiro Miura, Masanobu Kondo, Masateru Endo, Hideaki Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study |
title | Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study |
title_full | Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study |
title_fullStr | Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study |
title_full_unstemmed | Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study |
title_short | Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study |
title_sort | efficacy and safety of pemafibrate versus bezafibrate to treat patients with hypertriglyceridemia: a randomized crossover study |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244067/ https://www.ncbi.nlm.nih.gov/pubmed/37150612 http://dx.doi.org/10.5551/jat.ER63659 |
work_keys_str_mv | AT nakamuraakihiro efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy AT kagayayuta efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy AT saitohiroki efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy AT kanazawamasanori efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy AT satokenjiro efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy AT miuramasanobu efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy AT kondomasateru efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy AT endohideaki efficacyandsafetyofpemafibrateversusbezafibratetotreatpatientswithhypertriglyceridemiaarandomizedcrossoverstudy |